Transforming Companion Animal Health

 

Poïesis Therapeutics is a biotechnology start-up focused on sourcing and in-licensing innovative late stage therapeutics and diagnostics from human biomedical research and developing them to address unmet needs in the veterinary market for companion animals – horses, dogs and cats.

 

Product Pipeline Overview

One World.
One Medicine.
One Health.

 

Our mission statement adheres to the “one health” concept, reflective of the inherent synergies between animal and human medicine.

 

Therapeutics

Developing new medicines to address unmet needs in animal health.

Diagnostics

Developing new veterinary diagnostics to identify disorders in dogs, cats and horses.

Corporate Social Responsibility

Poïesis contributes a percentage of its profits to chosen charities which are making a difference for humans and animals.

Latest News

Shared Science: Human and Equine Health Similarities

By Sarah Evers Conrad, The Horse, September 9, 2016. Studying diseases across species can benefit horses as well as people -- Similarities between veterinary medicine and human medicine abound, particularly when it comes to horses. Horses, after all, suffer from many...

read more

Love of Pets Drives Animal Health on Wall Street: Report

   By Arlene Weintraub, FiercePharma Animal Health, August 29, 2016. Shares of animal health companies are outperforming the stock market as a whole, thanks largely to strong performances from companies like diagnostics maker IDEXX Laboratories ($IDXX), veterinary...

read more

Why Animal Health Is The Next Big Growth Area

By Cathy Yarbrough, Contributing Editor, Life Science Leader, July 1, 2016.   The animal health industry is on a growth trajectory, powered by the popularity of pet ownership and a global population hungry for meat and dairy products. The many large and small...

read more

PRESS RELEASES

 

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

.